Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sirius is an innovative biotech company focused on developing novel RNAi therapies for global markets. The company is dedicated to providing solutions for physicians and patients to manage cardiovascular diseases. Founded in 2021, Sirius has a world-class leadership team and investors. The company established an innovation, research, and development center in the United States and a translational center in China to address u...
Sirius is an innovative biotech company focused on developing novel RNAi therapies for global markets. The company is dedicated to providing solutions for physicians and patients to manage cardiovascular diseases. Founded in 2021, Sirius has a world-class leadership team and investors. The company established an innovation, research, and development center in the United States and a translational center in China to address unmet patient needs in chronic diseases. Leveraging RNAi technology, Sirius aims to offer a portfolio of solutions for patients to change the future of cardiovascular disease.

List your booth number for exhibitions, ask us